Publication | Open Access
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
50
Citations
29
References
2020
Year
Chinese Clinical Trial Registry (http://www.chictr.org.cn): ChiCTR-OOC-16007779.
| Year | Citations | |
|---|---|---|
Page 1
Page 1